Merck, SMB01013-1MG, Methyl 2,5-Dihydroxycinnamate

General description
Methyl 2,5-dihydroxycinnamate, a hydroxycinnamic acid, is a bioactive natural compound commonly derived from plants like Azadirachta indica and Murraya paniculata. Current research indicates that this plant-derived metabolite may possess diverse biological activities, encompassing anti-inflammatory and antitumor properties. Furthermore, it serves as a human urinary metabolite, a geroprotector, and an inhibitor of EC 2.7.10.1 (receptor protein-tyrosine kinase). It is a cell-permeable analog of erbstatin, a natural substance found in Streptomyces, demonstrates inhibitory effects on the autophosphorylation of the epidermal growth factor receptor. Moreover, it acts as a competitive inhibitor of epidermal growth factor receptor-associated tyrosine kinase, effectively impeding v-abl tyrosine kinase activation. Additionally, Methyl 2,5-dihydroxycinnamate has been observed to induce apoptosis in mouse thymocytes and inhibit the G2/M phase of the cell cycle.
Application
Methyl 2,5-Dihydroxycinnamate is a natural product derived from plant source that finds application in compound screening libraries, metabolomics, phytochemical, and pharmaceutical research.
Features and Benefits
Suitable for Biochemical and Biomedical research
Versatile and adaptable for wide variety of laboratory and research applications

Other Notes
For additional information on our range of Biochemicals, please complete this form.